Similar articles

• Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

  Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC. Henderson DC, et al. J Clin Psychiatry. 2005 Sep;66(9):1116-21. doi: 10.4088/jcp.v66n0905. J Clin Psychiatry. 2005. PMID: 16187768
• Prevalence and associations of the metabolic syndrome among patients prescribed clozapine.

  Ahmed M, Hussain I, O'Brien SM, Dineen B, Griffin D, McDonald C. Ahmed M, et al. Ir J Med Sci. 2008 Sep;177(3):205-10. doi: 10.1007/s11845-008-0156-9. Epub 2008 May 7. Ir J Med Sci. 2008. PMID: 18461270
• Parental history of diabetes mellitus has additive risk of metabolic syndrome in patients treated with clozapine.

  Zeng Y, Chen S, Liu D, Hahn L, Xia X, Wen S, Han Z, Wu X. Zeng Y, et al. Asian J Psychiatr. 2020 Apr;50:101939. doi: 10.1016/j.ajp.2020.101939. Epub 2020 Feb 11. Asian J Psychiatr. 2020. PMID: 32087501 No abstract available.
• A Focused Review of the Metabolic Side-Effects of Clozapine.

  Yuen JWY, Kim DD, Procyshyn RM, Panenka WJ, Honer WG, Barr AM. Yuen JWY, et al. Front Endocrinol (Lausanne). 2021 Feb 25;12:609240. doi: 10.3389/fendo.2021.609240. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716966 Free PMC article. Review.
• Consensus development conference on antipsychotic drugs and obesity and diabetes.

  American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. American Diabetes Association, et al. Obes Res. 2004 Feb;12(2):362-8. doi: 10.1038/oby.2004.46. Obes Res. 2004. PMID: 14981231 Review. No abstract available.